STOCK TITAN

Azitra (AZTR) director John R. Schroer receives 3,003 stock options grant

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Azitra, Inc. director John R. Schroer reported receiving a stock option grant. On 12/19/2025, he was granted options to purchase 3,003 shares of Azitra common stock at an exercise price of $0.2968 per share, with no purchase price for the option itself.

According to the vesting terms, 25% of the shares underlying the option vest on the grant date, designated as the vesting commencement date. The remaining shares vest in equal monthly installments over the next 36 months of continuous service. The options are scheduled to expire on 12/19/2035, and following this grant Schroer beneficially owns 3,003 derivative securities directly.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Schroer John R.

(Last) (First) (Middle)
21 BUSINESS PARK DRIVE

(Street)
BRANFORD CT 06405

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Azitra, Inc. [ AZTR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/19/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right To Buy) $0.2968 12/19/2025 A 3,003 (1) 12/19/2035 Common Stock 3,003 $0.00 3,003 D
Explanation of Responses:
1. 25% of the shares of the Company's Common Stock subject to the Option shall vest on the date of issuance, the Vesting Commencement Date, and the remaining balance shall vest in equal monthly installments over the next 36 months of continuous service thereafter.
/s/ John R. Schroer 12/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction was reported for Azitra (AZTR)?

Azitra (AZTR) director John R. Schroer reported receiving a grant of stock options on 12/19/2025. The options give him the right to buy 3,003 shares of Azitra common stock at an exercise price of $0.2968 per share.

What are the vesting terms of John R. Schroer’s Azitra stock options?

For this option grant, 25% of the Azitra common stock underlying the option vests on the grant date, described as the vesting commencement date. The remaining 75% vests in equal monthly installments over the next 36 months of continuous service.

What is the exercise price and expiration date of the Azitra options granted?

The options granted to John R. Schroer have an exercise price of $0.2968 per share. They are scheduled to expire on 12/19/2035, if not exercised or forfeited earlier under their terms.

How many Azitra derivative securities does John R. Schroer own after this transaction?

Following the reported transaction, John R. Schroer beneficially owns 3,003 derivative securities (stock options) in Azitra. These are reported as being held with direct ownership.

Is the Azitra Form 4 filing for an acquisition or a sale of securities?

The Form 4 reports an acquisition of derivative securities. Specifically, it shows John R. Schroer acquiring stock options (right to buy) relating to 3,003 shares of Azitra common stock.

What role does John R. Schroer have at Azitra (AZTR) according to this filing?

According to the filing, John R. Schroer is a director of Azitra, Inc. The relationship section is marked to indicate his status as a director, and the form is filed by one reporting person.

Azitra Inc

NYSE:AZTR

AZTR Rankings

AZTR Latest News

AZTR Latest SEC Filings

AZTR Stock Data

3.37M
10.19M
0.52%
3.42%
19.36%
Biotechnology
Pharmaceutical Preparations
Link
United States
BRANFORD